Printer Friendly

RETINAL: Retinal Imaging prevention and early detection of chronic diseases.

Total cost: EUR 71 429

EU contribution: EUR 50 000

Topic(s):ICT-37-2015-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument)

Call for proposal:H2020-SMEINST-1-2015See other projects for this call

Funding scheme:SME-1 - SME instrument phase 1

Objective: "The World Health Organization (WHO) in its Global status report on noncommunicable diseases 2014 shows that the impact of noncommunicable diseases (NCDs), also known as chronic diseases, is steadily growing. NCDs are the leading cause of death globally (68% of all deaths in 2012). The 4 main types of NCDs are cardiovascular (CVD) diseases (like cerebrovascular accidents or strokes and heart attacks), cancers, chronic respiratory diseases and diabetes. Cardiovascular diseases account for most NCD deaths (17.5 million people annually), followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).This proposal addresses the prevention and early diagnosis of 2 types of NCDs, Cardiovascular (CVD) diseases and diabetes, by providing health professionals a tool for automatic quantification of parameters of the retina and automatic detection of lesions of the retina, with capacity for prevention and/or early detection of various diseases.ULMA Embedded Solutions (UES) has developed a non-invasive and cost-effective tool for Automatic evaluation of Retinal Imaging Biomarkers (ARIB), which can be used in public health interventions delivered through a primary health-care approach to strengthen early detection and timely treatment of various diseases. Evidence shows that such interventions are excellent economic investments because, if applied to patients early, can reduce the need for more expensive treatment."

Coordinator

ULMA EMBEDDED SOLUTIONS S COOP

Spain

EU contribution: EUR 50 000

Project completion date : 2016-09-30 12:00:00

Major organization : ULMA EMBEDDED SOLUTIONS S COOP

Address : Garagaltza Auzoa 51

20560 Onati

Country :Spain

Email : info@ulmaembedded.com

Url : http://www.ulmaembedded.com/

Financier : EUROPEAN UNION (EU),WORLD HEALTH ORGANIZATION (WHO),

Financier address : European Union (EU)

Rue de la Loi 200/Wetstraat 200,

B-1049 Bruxelles/Brussels,

Belgium

Tel: 32-2-2999696, 2993085

Fax: 32-2-2961749

Url: ec.europa.eu/

[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).

COPYRIGHT 2016 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:May 11, 2016
Words:340
Previous Article:CRADL: Continuous Regional Analysis Device for neonate Lung.
Next Article:Etobicoke General Hospital Redevelopment.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters